Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Trastuzumab Cardiotoxicity × Exercise Test × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Trastuzumab Cardiotoxicity 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Heart Diseases 1 Cardiotoxicity 1 Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Exercise Test 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02615054 2024-04-11

Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors

Memorial Sloan Kettering Cancer Center

Trastuzumab Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡